{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:03:05Z","timestamp":1785542585759,"version":"3.56.0"},"reference-count":132,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00148","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T04:27:26Z","timestamp":1520224046000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children"],"prefix":"10.3389","volume":"9","author":[{"given":"Fr\u00e9d\u00e9rique","family":"Rodieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Vutskits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara M.","family":"Posfay-Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Habre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules A.","family":"Desmeules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline F.","family":"Samer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/pgpm.s48887","article-title":"Implementation and utilization of genetic testing in personalized medicine.","volume":"7","author":"Abul-Husn","year":"2014","journal-title":"Pharmacogenomics Person. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00540-010-0978-2","article-title":"Analgesic efficacy of topical tramadol in the control of postoperative pain in children after tonsillectomy.","volume":"24","author":"Akbay","year":"2010","journal-title":"J. Anesth."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2165\/00003088-200241130-00005","article-title":"Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.","volume":"41","author":"Alcorn","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"F24","DOI":"10.1136\/adc.2010.203851","article-title":"Efficacy of tramadol versus fentanyl for postoperative analgesia in neonates.","volume":"97","author":"Alencar","year":"2012","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"B5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4103\/aer.AER_23_17","article-title":"Comparison of intravenous infusion of tramadol alone with combination of tramadol and paracetamol for postoperative pain after major abdominal surgery in children.","volume":"11","author":"Ali","year":"2017","journal-title":"Anesth. Essays Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/bja\/aei170","article-title":"Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity.","volume":"95","author":"Allegaert","year":"2005","journal-title":"Br. J. Anaesth."},{"key":"B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40262-014-0191-9","article-title":"Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study.","volume":"54","author":"Allegaert","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666170926121124","article-title":"Developmental pharmacokinetics in neonates: maturational changes and beyond.","author":"Allegaert","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1460-9592.2010.03389.x","article-title":"Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance.","volume":"21","author":"Allegaert","year":"2011","journal-title":"Paediatr. Anaesth."},{"key":"B10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1358\/mf.2007.29.4.1106408","article-title":"Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life.","volume":"29","author":"Allegaert","year":"2007","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3959(00)00486-3","article-title":"Response variability to analgesics: a role for non-specific activation of endogenous opioids.","volume":"90","author":"Amanzio","year":"2001","journal-title":"Pain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/pan.13190","article-title":"Tramadol: keep calm and carry on.","volume":"27","author":"Anderson","year":"2017","journal-title":"Paediatr. Anaesth."},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00228-011-1093-5","article-title":"Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.","volume":"68","author":"Andreassen","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-016-0579-3","article-title":"Drug interaction and serotonin toxicity with opioid use: another reason to avoid opioids in headache and migraine treatment.","volume":"20","author":"Ansari","year":"2016","journal-title":"Curr. Pain Headache Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0304-3959(97)03350-2","article-title":"Respiratory depression following oral tramadol in a patient with impaired renal function.","volume":"71","author":"Barnung","year":"1997","journal-title":"Pain"},{"key":"B16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.forsciint.2014.03.003","article-title":"Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.","volume":"238","author":"Bastami","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations.","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B18","first-page":"395","article-title":"Tramadol, pharmacology, side effects, and serotonin syndrome: a review.","volume":"18","author":"Beakley","year":"2015","journal-title":"Pain Physician"},{"key":"B19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1472-8206.2000.tb00411.x","article-title":"Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies.","volume":"14","author":"Benedetti","year":"2000","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1634\/theoncologist.11-2-126","article-title":"Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.","volume":"11","author":"Bernard","year":"2006","journal-title":"Oncologist"},{"key":"B21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.siny.2004.11.001","article-title":"Ontogeny of drug metabolizing enzymes in the neonate.","volume":"10","author":"Blake","year":"2005","journal-title":"Semin. Fetal Neonatal Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5409\/wjcp.v2.i4.65","article-title":"Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis.","volume":"2","author":"Borgerding","year":"2013","journal-title":"World J. Clin. Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1542\/peds.2014-2096","article-title":"Tapentadol toxicity in children.","volume":"135","author":"Borys","year":"2015","journal-title":"Pediatrics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/bcpt.12586","article-title":"Evaluation of mutual drug-drug interaction within Geneva cocktail for cytochrome P450 phenotyping using innovative dried blood sampling method.","volume":"119","author":"Bosilkovska","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/clpt.2014.83","article-title":"Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.","volume":"96","author":"Bosilkovska","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.2042-7158.1981.tb13848.x","article-title":"The systemic bioavailability of buprenorphine by various routes of administration.","volume":"33","author":"Brewster","year":"1981","journal-title":"J. Pharm. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/cpt.176","article-title":"Human ontogeny of drug transporters: review and recommendations of the pediatric transporter working group.","volume":"98","author":"Brouwer","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012538.pub2","article-title":"Opioids for chronic non-cancer pain in children and adolescents.","volume":"7","author":"Cooper","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/clpt.2013.254","article-title":"Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.","volume":"95","author":"Crews","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"B31","article-title":"Tramadol therapy and CYP2D6 genotype","author":"Dean","year":"2012","journal-title":"Medical Genetics Summaries"},{"key":"B32","first-page":"7","article-title":"Clinical pharmacology and rationale of analgesic combinations.","volume":"28","author":"Desmeules","year":"2003","journal-title":"Eur. J. Anaesthesiol. Suppl."},{"key":"B33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.annemergmed.2009.06.005","article-title":"A randomized clinical trial of ibuprofen versus acetaminophen with codeine for acute pediatric arm fracture pain.","volume":"54","author":"Drendel","year":"2009","journal-title":"Ann. Emerg. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00228-011-1080-x","article-title":"Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer.","volume":"67","author":"Elkalioubie","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1399-6576.2012.02651.x","article-title":"Bayesian enhanced meta-analysis of post-operative analgesic efficacy of additives for caudal analgesia in children.","volume":"56","author":"Engelman","year":"2012","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1460-9592.2006.02030.x","article-title":"Tramadol infusion for the pain management in sickle cell disease: a case report.","volume":"17","author":"Erhan","year":"2007","journal-title":"Paediatr. Anaesth."},{"key":"B37","year":"2015","journal-title":"Codeine not to be Used in Children Below 12 Years for Cough and Cold."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1213\/00000539-200206000-00017","article-title":"An evaluation of the efficacy and tolerability of oral tramadol hydrochloride tablets for the treatment of postsurgical pain in children.","volume":"94","author":"Finkel","year":"2002","journal-title":"Anesth. Analg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00228-006-0250-8","article-title":"Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping.","volume":"63","author":"Frank","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5055\/jom.2015.0277","article-title":"Tramadol versus codeine\/acetaminophen after pediatric tonsillectomy: a prospective, double-blinded, randomized controlled trial.","volume":"11","author":"Friedrichsdorf","year":"2015","journal-title":"J. Opioid Manag."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.pcl.2012.07.003","article-title":"Pediatric pharmacokinetics: human development and drug disposition.","volume":"59","author":"Funk","year":"2012","journal-title":"Pediatr. Clin. North Am."},{"key":"B42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/gim.2016.80","article-title":"Prediction of CYP2D6 phenotype from genotype across world populations.","volume":"19","author":"Gaedigk","year":"2017","journal-title":"Genet. Med."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3479","article-title":"Pharmacogenetics for safe codeine use in sickle cell disease.","volume":"138","author":"Gammal","year":"2016","journal-title":"Pediatrics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF03256239","article-title":"Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.","volume":"11","author":"Gan","year":"2007","journal-title":"Mol. Diagn. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1007\/s11095-006-9049-7","article-title":"Population pharmacokinetic\/pharmacodynamic modelling of the analgesic effects of tramadol in pediatrics.","volume":"23","author":"Garrido","year":"2006","journal-title":"Pharm. Res."},{"key":"B46","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1016\/S0002-9343(96)00138-6","article-title":"Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl.","volume":"101","author":"Gibson","year":"1996","journal-title":"Am. J. Med"},{"key":"B47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s002100000266","article-title":"Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor.","volume":"362","author":"Gillen","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/fpc.0000000000000057","article-title":"PharmGKB summary: tramadol pathway.","volume":"24","author":"Gong","year":"2014","journal-title":"Pharmacogenet. Genomics"},{"key":"B49","first-page":"544","article-title":"Tramadol overdose and apnea in hospitalized children, a review of 20 cases.","volume":"10","author":"Hassanian-Moghaddam","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/0006-2952(82)90398-7","article-title":"Effect of the opioid analgesic tramadol on inactivation of norepinephrine and serotonin.","volume":"31","author":"Hennies","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/jpm2040201","article-title":"Insurance coverage policies for personalized medicine.","volume":"2","author":"Hresko","year":"2012","journal-title":"J. Person. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2165\/00003088-200645090-00005","article-title":"Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.","volume":"45","author":"Johnson","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1460-9592.1997.tb00488.x","article-title":"Recommended use of morphine in neonates, infants and children based on a literature review: part 2\u2013clinical use.","volume":"7","author":"Kart","year":"1997","journal-title":"Paediatr. Anaesth."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2217\/pgs.11.68","article-title":"Pharmacogenomics of the human micro-opioid receptor.","volume":"12","author":"Kasai","year":"2011","journal-title":"Pharmacogenomics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0014-2999(92)94822-D","article-title":"Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat.","volume":"224","author":"Kayser","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children.","volume":"349","author":"Kearns","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/JCP.0b013e318160f827","article-title":"Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.","volume":"28","author":"Kirchheiner","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.tpj.6500406","article-title":"Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.","volume":"7","author":"Kirchheiner","year":"2007","journal-title":"Pharmacogenomics J."},{"key":"B60","first-page":"681","article-title":"Tramadol\u2013the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain.","volume":"53","author":"Klotz","year":"2003","journal-title":"Arzneimittelforschung"},{"key":"B61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/187231208783478434","article-title":"Investigations into the drug-drug interaction potential of tapentadol in human liver microsomes and fresh human hepatocytes.","volume":"2","author":"Kneip","year":"2008","journal-title":"Drug Metab. Lett."},{"key":"B62","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s40262-015-0268-0","article-title":"The pharmacogenetics of tramadol.","volume":"54","author":"Lassen","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.clpt.2004.11.002","article-title":"Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol.","volume":"77","author":"Laugesen","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/00003495-199346020-00008","article-title":"Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.","volume":"46","author":"Lee","year":"1993","journal-title":"Drugs"},{"key":"B65","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ejps.2010.08.005","article-title":"Glucuronidation of racemic O-desmethyltramadol, the active metabolite of tramadol.","volume":"41","author":"Lehtonen","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4097\/kjae.2017.70.2.184","article-title":"Comparison of single-dose nalbuphine versus tramadol for postoperative pain management in children: a randomized, controlled trial.","volume":"70","author":"Liaqat","year":"2017","journal-title":"Korean J. Anesthesiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1517\/17425255.2014.964204","article-title":"Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.","volume":"10","author":"Llerena","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5863\/1551-6776-19.4.262","article-title":"Developmental pharmacokinetics in pediatric populations.","volume":"19","author":"Lu","year":"2014","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology.","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr. Neuropharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1213\/00000539-199310000-00007","article-title":"Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery.","volume":"77","author":"Lynn","year":"1993","journal-title":"Anesth. Analg."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ejp.632","article-title":"Use of prescribed opioids by children and adolescents: differences between Denmark, Norway and Sweden.","volume":"19","author":"Mahic","year":"2015","journal-title":"Eur. J. Pain"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s00405-017-4477-z","article-title":"Comparing the effects of peritonsillar infiltration of tramadol before and after the surgery on post-tonsillectomy pain.","volume":"274","author":"Maryam","year":"2017","journal-title":"Eur. Arch. otorhinolaryngol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1213\/ane.0000000000001683","article-title":"Trends in tramadol: pharmacology, metabolism, and misuse.","volume":"124","author":"Miotto","year":"2017","journal-title":"Anesth. Analg."},{"key":"B74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/070674370805300305","article-title":"Trends in psychostimulant and antidepressant use by children in 2 Canadian provinces.","volume":"53","author":"Mitchell","year":"2008","journal-title":"Can. J. Psychiatry"},{"key":"B75","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/acem.12431","article-title":"The effect of CYP2D6 drug-drug interactions on hydrocodone effectiveness.","volume":"21","author":"Monte","year":"2014","journal-title":"Acad. Emerg. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2165\/00003088-198005060-00001","article-title":"Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications.","volume":"5","author":"Morselli","year":"1980","journal-title":"Clin. Pharmacokinet."},{"key":"B77","first-page":"124","article-title":"A pilot study of nalbuphine versus tramadol administered through continuous intravenous infusion for postoperative pain control in children.","volume":"80","author":"Moyao-Garcia","year":"2009","journal-title":"Acta Biomed."},{"key":"B78","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/oxfordjournals.bja.a013437","article-title":"Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration.","volume":"84","author":"Murthy","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"B79","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/archdischild-2012-303527","article-title":"Sublingual ketorolac versus sublingual tramadol for moderate to severe post-traumatic bone pain in children: a double-blind, randomised, controlled trial.","volume":"98","author":"Neri","year":"2013","journal-title":"Arch. Dis. Child."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e753","DOI":"10.1542\/peds.2014-2673","article-title":"A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol.","volume":"135","author":"Orliaguet","year":"2015","journal-title":"Pediatrics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/phar.1986","article-title":"Review of opioid pharmacogenetics and considerations for pain management.","volume":"37","author":"Owusu Obeng","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B82","author":"Patterson","year":"2017","journal-title":"Tramadol History and Statistics."},{"key":"B83","first-page":"109","article-title":"Pharmacokinetics of oral tramadol drops for postoperative pain relief in children aged 4 to 7 years\u2013a pilot study.","volume":"49","author":"Payne","year":"2002","journal-title":"Anesth. Prog."},{"key":"B84","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00228-006-0135-x","article-title":"Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.","volume":"62","author":"Pedersen","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B85","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)11227-5","article-title":"Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an \u2019atypical\u2019 opioid analgesic.","volume":"260","author":"Raffa","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-3565(25)39454-1","article-title":"Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.","volume":"267","author":"Raffa","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00008571-200010000-00001","article-title":"Elucidation of the genetic basis of the common \u2018intermediate metabolizer\u2019 phenotype for drug oxidation by CYP2D6.","volume":"10","author":"Raimundo","year":"2000","journal-title":"Pharmacogenetics"},{"key":"B88","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1081\/dmr-120001392","article-title":"Summary of information on human CYP enzymes: human P450 metabolism data.","volume":"34","author":"Rendic","year":"2002","journal-title":"Drug Metab. Rev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/jcph.721","article-title":"Causes and consequences of variability in drug transporter activity in pediatric drug therapy.","author":"Rodieux","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2217\/14622416.9.7.905","article-title":"Pharmacogenetics of analgesics: toward the individualization of prescription.","volume":"9","author":"Rollason","year":"2008","journal-title":"Pharmacogenomics"},{"key":"B91","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00000542-200503000-00008","article-title":"Polymorphism of mu-opioid receptor gene (OPRM1:c.118A > G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.","volume":"102","author":"Romberg","year":"2005","journal-title":"Anesthesiology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1213\/00000539-200301000-00016","article-title":"Oral tramadol for the treatment of pain of 7-30 days\u2019 duration in children.","volume":"96","author":"Rose","year":"2003","journal-title":"Anesth. Analg."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00228-012-1460-x","article-title":"Rifampicin markedly decreases the exposure to oral and intravenous tramadol.","volume":"69","author":"Saarikoski","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40262-014-0140-7","article-title":"A re-evaluation and validation of ontogeny functions for cytochrome P450 1A2 and 3A4 based on in vivo data.","volume":"53","author":"Salem","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1476-5381.2010.00709.x","article-title":"Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety.","volume":"160","author":"Samer","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1476-5381.2010.00673.x","article-title":"The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.","volume":"160","author":"Samer","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40291-013-0028-5","article-title":"Applications of CYP450 testing in the clinical setting.","volume":"17","author":"Samer","year":"2013","journal-title":"Mol. Diagn. Ther."},{"key":"B98","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.annfar.2007.03.015","article-title":"[Pharmacokinetics of tramadol in children].","volume":"26","author":"Saudan","year":"2007","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"B99","first-page":"408","article-title":"[Nalbuphine and tramadol for the control of postoperative pain in children].","volume":"35","author":"Schaffer","year":"1986","journal-title":"Anaesthesist"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009574.pub2","article-title":"Tramadol for postoperative pain treatment in children.","volume":"3","author":"Schnabel","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1073\/pnas.0730858100","article-title":"Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1.","volume":"100","author":"Shu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B102","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4149\/BLL_2012_036","article-title":"Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms.","volume":"113","author":"Slanar","year":"2012","journal-title":"Bratisl. Lek. Listy"},{"key":"B103","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/pgpm.s136341","article-title":"CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications.","volume":"10","author":"St Sauver","year":"2017","journal-title":"Pharmacogenomics Pers. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0304-3959(03)00212-4","article-title":"Impact of CYP2D6 genotype on postoperative tramadol analgesia.","volume":"105","author":"Stamer","year":"2003","journal-title":"Pain"},{"key":"B105","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/sj.clpt.6100152","article-title":"Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.","volume":"82","author":"Stamer","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1097\/j.pain.0000000000000662","article-title":"Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.","volume":"157","author":"Stamer","year":"2016","journal-title":"Pain"},{"key":"B107","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1213\/ane.0b013e31817b796e","article-title":"Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.","volume":"107","author":"Stamer","year":"2008","journal-title":"Anesth. Analg."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1097\/pec.0000000000001084","article-title":"Characterizing the toxicity and dose-effect profile of tramadol ingestions in children.","author":"Stassinos","year":"2017","journal-title":"Pediatr. Emerg. Care"},{"key":"B109","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cca.2013.11.015","article-title":"Hydrocodone in postoperative personalized pain management: pro-drug or drug?","volume":"429","author":"Stauble","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"B110","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/clpt.2011.34","article-title":"Pharmacogenetics: from bench to byte\u2013an update of guidelines.","volume":"89","author":"Swen","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B111","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4103\/0019-5049.82667","article-title":"Tramadol-induced respiratory depression in a morbidly obese patient with normal renal function.","volume":"55","author":"Tantry","year":"2011","journal-title":"Indian J. Anaesth."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/S0024-3205(97)01011-4","article-title":"A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy.","volume":"61","author":"Tateishi","year":"1997","journal-title":"Life Sci."},{"key":"B113","volume":"20","year":"2017"},{"key":"B114","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.clpt.2004.08.017","article-title":"Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients.","volume":"76","author":"Tirkkonen","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1208\/s12248-015-9803-z","article-title":"Physiologically based pharmacokinetic predictions of tramadol exposure throughout pediatric life: an analysis of the different clearance contributors with emphasis on CYP2D6 maturation.","volume":"17","author":"T\u2019Jollyn","year":"2015","journal-title":"AAPS J."},{"key":"B116","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1432-1033.1991.tb16411.x","article-title":"Expression of CYP2D6 in developing human liver.","volume":"202","author":"Treluyer","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1177\/1060028015604631","article-title":"Comparative toxicity of tapentadol and tramadol utilizing data reported to the national poison data system.","volume":"49","author":"Tsutaoka","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"B118","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","article-title":"Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.","volume":"86","author":"Tzvetkov","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/clpt.2011.56","article-title":"Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol.","volume":"90","author":"Tzvetkov","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B120","year":"2015","journal-title":"FDA Drug Safety Communication: FDA Evaluating the Risks of Using the Pain Medicine Tramadol in Children Aged 17 and Younger."},{"key":"B121","year":"2017","journal-title":"FDA Drug Safety Communication: FDA Restricts Use of Prescription Codeine Pain and Cough Medicines and Tramadol Pain Medicines in Children; Recommends Against use in Breastfeeding Women."},{"key":"B122","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jclinane.2010.07.001","article-title":"The efficacy of intravenous paracetamol versus tramadol for postoperative analgesia after adenotonsillectomy in children.","volume":"23","author":"Uysal","year":"2011","journal-title":"J. Clin. Anesth."},{"key":"B123","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cpdd.169","article-title":"Single- and multiple-dose pharmacokinetic studies of tramadol immediate-release tablets in children and adolescents.","volume":"4","author":"Vandenbossche","year":"2015","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B124","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cpdd.266","article-title":"Single-dose pharmacokinetic study of tramadol extended-release tablets in children and adolescents.","volume":"5","author":"Vandenbossche","year":"2016","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.biopha.2015.01.022","article-title":"Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems.","volume":"70","author":"Vazzana","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"B126","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses.","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012564.pub2","article-title":"Opioids for cancer-related pain in children and adolescents.","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B128","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3821\/145.6.cpj276","article-title":"Pain management in children: Part 2 - A transition from codeine to morphine for moderate to severe pain in children.","volume":"145","author":"Wong","year":"2012","journal-title":"Can. Pharm. J."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/scs.0000000000001250","article-title":"Comparison of different administration of ketamine and intravenous tramadol hydrochloride for postoperative pain relief and sedation after pediatric tonsillectomy.","volume":"26","author":"Yenigun","year":"2015","journal-title":"J. Craniofac. Surg."},{"key":"B130","doi-asserted-by":"publisher","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.","volume":"280","author":"Zhang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B131","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"B132","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archpedi.157.1.17","article-title":"Psychotropic practice patterns for youth: a 10-year perspective.","volume":"157","author":"Zito","year":"2003","journal-title":"Arch. Pediatr. Adolesc. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00148\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:46:18Z","timestamp":1751449578000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00148\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":132,"alternative-id":["10.3389\/fphar.2018.00148"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00148","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"article-number":"148"}}